-
1
-
-
84988223408
-
Epidemiology of restless legs syndrome in adults
-
Philips B et al. Epidemiology of restless legs syndrome in adults. Arch. Intern. Med. 160: 137, 2000.
-
(2000)
Arch. Intern. Med.
, vol.160
, pp. 137
-
-
Philips, B.1
-
2
-
-
0029129647
-
Toward a better definition of the restless legs syndrome. International Restless legs syndrome Study Group
-
Walter AS. Toward a better definition of the restless legs syndrome. International Restless legs syndrome Study Group. Mov. Disord. 10: 634, 1995.
-
(1995)
Mov. Disord.
, vol.10
, pp. 634
-
-
Walter, A.S.1
-
3
-
-
38049087118
-
RLS epidemiology, frequencies, risk factors and methods in population studies
-
Berger K, Kurth T. RLS epidemiology, frequencies, risk factors and methods in population studies. Mov Disord 2007; 22 (Suppl 18): S420-3.
-
(2007)
Mov Disord
, vol.22
, Issue.SUPPL. 18
-
-
Berger, K.1
Kurth, T.2
-
4
-
-
0037947320
-
Restless legs syndrome: N
-
Earley CJ Restless legs syndrome: N. Eng. J. Med 348:2103 2003
-
(2003)
Eng. J. Med
, vol.348
, pp. 2103
-
-
Earley, C.J.1
-
5
-
-
0036344976
-
Prevalence of restless legs syndrome and periodic limb movement disorder in the general population
-
Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002; 53: 547 e 54.
-
(2002)
J Psychosom Res
, vol.53
, pp. 547-554
-
-
Ohayon, M.M.1
Roth, T.2
-
6
-
-
34548025611
-
Pathophysiological concepts of restless legs syndrome
-
Paulus W, Dowling P, Rijsman R, et al. Pathophysiological concepts of restless legs syndrome. Mov Disord 2007; 22: 1451-6.
-
(2007)
Mov Disord
, vol.22
, pp. 1451-1456
-
-
Paulus, W.1
Dowling, P.2
Rijsman, R.3
-
7
-
-
79953174586
-
Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study
-
Apr
-
Malaguarnera M, Vacante M, Giordano M, Pennisi G, Bella R, Rampello L, Malaguarnera M, Li Volti G, Galvano F. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr. 2011 Apr; 93(4): 799-808.
-
(2011)
Am J Clin Nutr
, vol.93
, Issue.4
, pp. 799-808
-
-
Malaguarnera, M.1
Vacante, M.2
Giordano, M.3
Pennisi, G.4
Bella, R.5
Rampello, L.6
Malaguarnera, M.7
Li Volti, G.8
Galvano, F.9
-
8
-
-
83655192001
-
Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial
-
Dec
-
Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, Nunnari G, Rampello L, Pennisi G. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metab Brain Dis. 2011 Dec; 26(4): 281-9.
-
(2011)
Metab Brain Dis
, vol.26
, Issue.4
, pp. 281-289
-
-
Malaguarnera, M.1
Vacante, M.2
Motta, M.3
Giordano, M.4
Malaguarnera, G.5
Bella, R.6
Nunnari, G.7
Rampello, L.8
Pennisi, G.9
-
9
-
-
79955949749
-
Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy
-
Jun
-
Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, Motta M, Mistretta A, Rampello L, Pennisi G. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol. 2011 Jun; 46(6): 750-9.
-
(2011)
Scand J Gastroenterol
, vol.46
, Issue.6
, pp. 750-759
-
-
Malaguarnera, M.1
Bella, R.2
Vacante, M.3
Giordano, M.4
Malaguarnera, G.5
Gargante, M.P.6
Motta, M.7
Mistretta, A.8
Rampello, L.9
Pennisi, G.10
|